Lauren Walliser
Nurse Practitioner · Ooltewah, TNNPI 1023597341
Payments from drug & device makers
Across 285 payments — averaging $14.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$908
- AstraZeneca$362
- Novo Nordisk$346
- Lilly USA, LLC$327
- Otsuka America Pharmaceutical, Inc.$255
- Supernus Pharmaceuticals, Inc.$248
- plus $2K from 33 others
What the payments were for
- Food & beverage$4,053100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$4,065 in reported general payments places this provider in the 85th percentile of 2,662 nurse practitioner providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 44 | $63,390 |
| OzempicSemaglutide | 31 | $47,371 |
| JardianceEmpagliflozin | 33 | $36,704 |
| FarxigaDapagliflozin Propanediol | 18 | $18,922 |
| EliquisApixaban | 23 | $13,248 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $11,295 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $1,429 |
| Omeprazole | 71 | $1,335 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 31 | $1,310 |
| Hydroxychloroquine Sulfate | 19 | $1,222 |
| Insulin Glargine-Yfgn | 11 | $1,045 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 37 | $937 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 33 | $752 |
| Duloxetine Hcl | 26 | $710 |
| Gabapentin | 69 | $705 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $327 | $63,39044 claims |
| Novo NordiskOzempic | $346 | $47,37131 claims |
| AstraZenecaFarxiga | $362 | $18,92218 claims |
| PfizerEliquis | $127 | $13,24823 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,662 nurse practitioner providers in Tennessee.
Other nurse practitioner in Ooltewah
- S Marie HamiltonOoltewah$64K
- Amy HatcherMurfreesboro$1.1M
- Karen RodenKnoxville$265K
- Susan UtleyNashville$194K
- Whitney EricksonMemphis$159K
- Erica HembreeKnoxville$125K
- Brooke FaughtNashville$89K
- Lauren WelchNashville$71K
- Cara StoutKingsport$71K
- Cynthia WilsonChattanooga$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.